Galantamine
Vérifier sur psychonaut
Galanthamine
Vérifier sur isomerdesign
Galantamin
Vérifier sur pubchem
Galantamine
Vérifier sur pubchem
Galantamine
Vérifier sur drugmap
Galantamine
Vérifier sur wiki
Data
InChI: InChI=1S/C17H21NO3/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17/h3-6,12,14,19H,7-10H2,1-2H3
Synonymes: Pharmakon1600-01501202,BRD-K49481516-004-04-3,DTXSID2045606,Q-201144,MLS000766281,Galanthaminum, Razadyne (TN),(4aS,6R,8aS)-4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofuro(3a,3,2-ef)(2)benzazepin-6-ol,galanthamine,DTXSID70859345, Nivalin (TN), Galantamina [INN-Spanish],BSPBio_003416,ASUTZQLVASHGKV-JDFRZJQESA-,AS-56354,(1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol,(-)Galanthamine,AB00053614-09,GALANTAMINE [USAN], (4aS,6R,8aS)-4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofuro(3a,3,2-ef)(2)benzazepin-6-ol,SCHEMBL3293474,1T835Z585R,(1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6,8,10(17),15-tetraen-14-ol,(-)-Galantamine,Epigalanthamin, Galantamin,BPBio1_000480,DSSTox_CID_25606,KBio3_002636,CCG-212961,AKOS000635322,GALANTAMINE [MI],BIDD:GT0517,HMS3561F13,NSC759861, Galanthamine, Lycoremin, Galantamine [USAN:INN],STL146336,(4aS,6R,8aS)-4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-ol,GNT,GTPL6693,UNII-0D3Q044KCA,Ent-Galantamine,NSC-100058,Galantamine (USAN/INN),NCGC00017256-05,Reminyl (TN),1qti, Galanthaminum,CHEMBL1623394, Razadyne ER,Bodamine,FT-0668942,357G700,AKOS015965330,NCGC00017256-11, Galantaminum, Lycoremine,KBio2_006887, Galantamina,(4aS,6R,8aS)-4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofurol[3a,3,2,-ef][2]benzazepin-6-ol,Probes2_000395,AM62710,Galantamine; HSDB 7361,BCP28966,CAS-357-70-0,KBio1_000590,NCGC00024731-02,CERAPP_13557,Spectrum4_000839,s3866,NCGC00017256-17,LSM-1597,SMP1_000131,Prestwick2_000588,DivK1c_000590,Tox21_110807,Spectrum5_001673, Galantamine (USAN/INN),(1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12.0^{6,17]heptadeca-6(17),7,9,15-tetraen-14-ol,UNII-1T835Z585R,BRD-K49481516-004-09-2,epigalanthamine,6H-BENZOFURO(3A,3,2-EF)(2)BENZAZEPIN-6-OL, 4A,5,9,10,11,12-HEXAHYDRO-3-METHOXY-11-METHYL-, (4AS,6R,8AS),Probes1_000055,0D3Q044KCA,(4aS,6R,8aS)-3-Methoxy-11-methyl-5,6,9,10,11,12-hexahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-6-ol,NSC100058,Prestwick3_000588,FT-0668941,1dx6,HSDB 7361, (-)-Galanthamine,SBI-0051689.P002,Oprea1_098077,SCHEMBL220427,Galanthamine, (+/-)-,(-)-Galanthamine,SMR000528869,Razadyne,EN300-708805,Galantaminum,SCHEMBL2577,AC-34328, Reminyl (TN),SR-05000001783,6H-Benzofuro[3a,2-ef][2]benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, [4aS-(4a.alpha.,6.beta.,8aR*)]-,BBL028838,6H-Benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aS-(4a.alpha.,6.beta.,8aR*))-,Galantamine, (+/-)-,Spectrum3_001738,KBioGR_001417,Galantamine [USAN:INN:BAN], Galantaminum [INN-Latin],Galanthamine, 12,23173-12-8,6H-Benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aS,6R,8aS)-,GALANTAMINE [HSDB],BDBM10404,DSSTox_RID_80999,HMS2269H23,FT-0667895,GALANTAMINE [WHO-DD],HY-76299,4-27-00-02184 (Beilstein Handbook Reference),FT-0668943,KBio2_004319,AB00053614_10,Q412690, Jilkon,Galanthamine HBr,357-70-0,Galantamina [INN-Spanish],9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol,AC-20240,Oprea1_097473,GALANTAMINE [INN],Spectrum_001271,HMS2089H03,(1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6(17),7,9,15-tetraen-14-ol,GALANTAMINE [VANDF],BRD-A49148672-001-07-9,(4aS,6R,8aS)-3-methoxy-11-methyl-4a,5,9,10,11,12-hexahydro-6H-benzo[2,3]benzofuro[4,3-cd]azepin-6-ol,NCGC00017256-04,Galanthamine,(3.alpha.-, Razadyne ER (TN),CS-1217,SDCCGMLS-0066737.P001,Galanthamine #, Reminyl,6H-Benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aR,6S,8aR)-rel-,SR-05000001783-4,(+/-)-Galantamine,Prestwick1_000588,CHEMBL659,D04292,NSC-759861,Lycoremine,NSC 100058,Lycoremin,Galantaminum [INN-Latin],SPBio_002655,1008759-59-8,BRD-K49481516-004-03-5,MFCD00867189,ZINC491073,HMS3885C10,Dihydrogalantamine,(+/-)-Galanthamine,BSPBio_000436,(4aS,6R,8aS)-3-Methoxy-11-methyl-5,6,9,10,11,12-hexahydro-4aH-benzo[2,3]benzofuro[4,3-cd]azepin-6-ol,DSSTox_GSID_45606,BRD-A49148672-004-01-6,Galanthamine,KBio2_001751,NINDS_000590,C08526,NCI60_000004,CHEBI:42944,CHEBI:91735,Galantamina,DB00674,KBioSS_001751,6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aS,6R,8aS)-,Jilkon,BRN 0093736,6H-BENZOFURO(3A,3,2-EF)(2)BENZAZEPIN-6-OL, 4A,5,9,10,11,12-HEXAHYDRO-3-METHOXY-11-METHYL-, (4A.ALPHA.,6.BETA.,8AR*)-,Prestwick0_000588,6H-Benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aalpha,6beta,8ar*)-,Q27163546,Razadyne ER,IDI1_000590
Estimated data
Solubility: -2.356 (log(S) in mol/L prediction using SolTranNet)
Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)
Addictivity Prediction: 76.3% (prediction based on www.mdpi.com)
